Kenneth B. Ain
#71,401
Most Influential Person Now
American endocrinologist
Kenneth B. Ain's AcademicInfluence.com Rankings
Kenneth B. Ainbiology Degrees
Biology
#15541
World Rank
#19547
Historical Rank
Endocrinology
#234
World Rank
#251
Historical Rank
Download Badge
Biology
Kenneth B. Ain's Degrees
- Doctorate Medicine University of Pennsylvania
- Bachelors Biology University of Pennsylvania
Similar Degrees You Can Earn
Why Is Kenneth B. Ain Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kenneth B. Ain is an American endocrinologist and Carmen L. Buck Chair and Professorship of Cancer Research and Oncology at the University of Kentucky, and also currently a licensed doctor and published author, being collected by libraries worldwide.
Kenneth B. Ain's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. (2012) (711)
- Outcomes of patients with differentiated thyroid carcinoma following initial therapy. (2006) (619)
- American Thyroid Association guidelines for detection of thyroid dysfunction. (2000) (594)
- High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. (2003) (453)
- Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. (1995) (346)
- Prospective multicenter study of thyroid carcinoma treatment (1998) (328)
- Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. (1998) (308)
- Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. (2000) (299)
- Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. (1998) (273)
- Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. (1998) (254)
- Thyroid cancer: a lethal endocrine neoplasm. (1991) (247)
- Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status. (1999) (227)
- Recurrence after treatment of micropapillary thyroid cancer. (2009) (181)
- Anaplastic thyroid carcinoma: a therapeutic challenge. (1999) (167)
- The impact of age and gender on papillary thyroid cancer survival. (2012) (166)
- Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. (1998) (166)
- Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. (2002) (152)
- Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma. (1999) (146)
- Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. (1997) (133)
- Papillary thyroid carcinoma. Etiology, assessment, and therapy. (1995) (130)
- Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro. (2006) (120)
- Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012. (2015) (117)
- Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis. (2014) (111)
- Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells. (1998) (101)
- TRAIL Death Pathway Expression and Induction in Thyroid Follicular Cells* (1999) (97)
- Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E (1999) (95)
- Role of spermine in amyloid β‐peptide‐associated free radical‐induced neurotoxicity (2001) (91)
- Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo. (1996) (88)
- Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas. (2007) (85)
- Radioiodine therapy in patients with stage I differentiated thyroid cancer. (2010) (81)
- Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. (1994) (77)
- Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. (2004) (72)
- Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1 (2002) (67)
- Cloning of the human sodium-iodide symporter promoter and characterization in a differentiated human thyroid cell line, KAT-50. (1998) (63)
- Combretastatin A4 phosphate has primary antineoplastic activity against human anaplastic thyroid carcinoma cell lines and xenograft tumors. (2002) (62)
- Management of undifferentiated thyroid cancer. (2000) (54)
- Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. (2003) (46)
- Phase II study of lenalidomide in distantly metastatic, rapidly progressive, and radioiodine-unresponsive thyroid carcinomas: preliminary results (2008) (42)
- Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients. (1993) (40)
- Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy (1995) (39)
- Papillary endothelial hyperplasia in the thyroid following fine-needle aspiration. (1991) (36)
- Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro. (2004) (34)
- Reversible cognitive, motor, and driving impairments in severe hypothyroidism. (2015) (32)
- KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin-releasing hormone. (1998) (32)
- Erratum: American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer (Thyroid (2012) 22:11 (1104-1139)) (2012) (32)
- Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma (2011) (29)
- Assessment of fine‐needle aspiration sampling technique in thyroid nodules (1998) (27)
- Radioiodine-remnant ablation in low-risk differentiated thyroid cancer: pros (2015) (22)
- Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in human thyroid adenoma cell line, KAK-1, suggesting trans-active transcriptional repressor. (2007) (21)
- Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells. (2010) (20)
- Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis. (2015) (19)
- False‐Positive I‐131 Uptake at a Tracheostomy Site Discernment With TI‐201 Imaging (1994) (18)
- Butyrate alters the expression and activity of cell cycle components in anaplastic thyroid carcinoma cells. (2001) (17)
- Quality of life impact of external beam radiotherapy for advanced thyroid carcinoma. (2013) (15)
- Low-Iodine Tube-Feeding Diet for lodine-131 Scanning and Therapy (1994) (15)
- A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene. (1998) (14)
- Erratum: American thyroid association guidelines for detection of thyroid dysfunction (Archives of Internal Medicine (2000) 160 (1573-1575)) (2001) (13)
- Unusual Types of Thyroid Cancer (2000) (12)
- Protein kinase inhibitor therapy in advanced thyroid cancer: ethical challenges and potential solutions (2014) (9)
- Association of Radioactive Iodine Treatment of Hyperthyroidism with Cancer Mortality: an Unjustified Warning? (2019) (8)
- Effects of Restricting Levothyroxine Dosage Strength Availability (1996) (7)
- Polyamine synthesis and transport inhibition in a human anaplastic thyroid carcinoma cell line in vitro and as xenograft tumors. (1999) (7)
- Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs. (2012) (6)
- Management of Thyroid Cancer (1997) (4)
- Rare Forms of Thyroid Cancer (1998) (4)
- Problematic clinical trials in thyroid cancer: the issue of papillary carcinoma and observational approaches (2017) (3)
- Pathobiology of antineoplastic therapy in undifferentiated thyroid cancer. (2004) (3)
- Medullary thyroid carcinoma imaged by Tc-99m MIBI SPECT and Tl-201 chloride/Tc-99m pertechnetate subtraction SPECT. (1996) (3)
- Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human thyroid cancer cell linein vitro andin vivo (1996) (3)
- Systemic embolism in thyrotoxicosis without cardiac arrhythmia. (1994) (2)
- Primary Thyroid Lymphoma: A Comprehensive Assessment and Clinical Approach (1999) (2)
- Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human thyroid cancer cell line in vitro and in vivo. (1996) (1)
- Patterns of automotive safety restraint use in rhode island: impact of the child passenger restraint law. (1981) (1)
- Abstract Digest (1995) (0)
- Iodine Uptake Restoration in Thyroid Cancer (2017) (0)
- Human Thyroid Carcinoma Papillary , Follicular , Hurthle ' s Cell , and Poorly Differentiated Distinct Patterns of E-Cadherin CpG Island Methylation in Updated (2006) (0)
- Excellent long-term control in locoregionally recurrent radioactive iodine-refractory papillary thyroid cancer with the addition of external beam radiation therapy to maximal surgical resection. (2012) (0)
- The use of iodine 131 dosimetry in the treatment of thyroid carcinoma (1990) (0)
- External Beam Radiotherapy in the Management of Recurrent I-131 Refractory Thyroid Cancer (2008) (0)
- Systemic Treatment for Unresectable Thyroid Carcinoma: Comprehensive Approach (2012) (0)
- The Reluctant Chef (2006) (0)
- The Reluctant Chef (2006) (0)
- Discussion on radioactive iodine treatment of hyperthyroidism and the risk of induced cancer (2020) (0)
- The Fatigued Attorney (2006) (0)
- Chapter 27 – Follicular Carcinoma (2009) (0)
- External Beam Radiation Therapy in Radioactive Iodine Refractory Thyroid Carcinoma: Long-Term Outcomes and Side Effects (2017) (0)
- Management of undiÄerentiated thyroid cancer (2000) (0)
- Locoregional control following external beam radiotherapy for recurrent, I-131 refractory thyroid 26061 cancer (2008) (0)
- Genomic DNA Extraction and PCR Amplification of Exon 15 of the BRAF Gene and Exons 1 and 2 of the NRAS Gene (2003) (0)
This paper list is powered by the following services:
Other Resources About Kenneth B. Ain
What Schools Are Affiliated With Kenneth B. Ain?
Kenneth B. Ain is affiliated with the following schools:
